Nektar Therapeutics
NKTR
NKTR
142 hedge funds and large institutions have $1.05B invested in Nektar Therapeutics in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $1.18B → $1.05B (-$128M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
142
Holding in Top 10
1
Calls
$17.9M
Puts
$10.1M
Top Buyers
| 1 | +$24.8M | |
| 2 | +$9.34M | |
| 3 | +$6.99M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.95M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$6.38M |
Top Sellers
| 1 | -$46.2M | |
| 2 | -$34M | |
| 3 | -$10.5M | |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$9.35M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.88M |